Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial
Articolo
Data di Pubblicazione:
2015
Abstract:
Non-pegylated liposomal doxorubicin (NPLD) has demonstrated antitumour activity equivalent to conventional doxorubicin and a significantly lower risk of cardiotoxicity. This phase II trial was performed to evaluate the activity and the safety of NPLD and ifosfamide combination in patients with metastatic soft tissue sarcoma.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
non-pegylated liposomal doxorubicin; phase II; soft tissue sarcoma
Elenco autori:
DE SANCTIS, Rita; Bertuzzi, Alexia; Basso, Umberto; Comandone, Alessandro; Marchetti, Silvia; Marrari, Andrea; Colombo, Piergiuseppe; Lutman, Romano Fabio; Giordano, Laura; Santoro, Armando
Link alla scheda completa:
Pubblicato in: